| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 0.37▲ | 0.36▲ | 0.36▲ | 0.38▼ | 0.33▲ |
| MA10 | 0.37▼ | 0.37▼ | 0.37▼ | 0.38▼ | 0.40▼ |
| MA20 | 0.37▼ | 0.38▼ | 0.37▼ | 0.36▲ | N/A |
| MA50 | 0.37▼ | 0.37▼ | 0.37▼ | 0.41▼ | N/A |
| MA100 | 0.38▼ | 0.38▼ | 0.39▼ | N/A | N/A |
| MA200 | 0.37▼ | 0.37▼ | 0.39▼ | N/A | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.001▼ | -0.002▼ | -0.002▼ | 0.007▲ | N/A |
| RSI | 42.519▼ | 44.671▼ | 45.630▼ | 47.344▼ | 20.062▼ |
| STOCH | 21.728 | 14.331▼ | 14.391▼ | 27.004 | N/A |
| WILL %R | -73.684 | -79.245▼ | -84.507▼ | -72.465 | -77.368▼ |
| CCI | -54.554 | -72.337 | -74.764 | -46.424 | -54.380 |
|
Sunday, June 01, 2025 05:00 PM
10 Stocks to Sell NOW! 3 Stocks to DOUBLE This Year The 10 Best Stocks to Own in 2023 7 Stocks to Buy and Hold Forever Aspire Biopharma Holdings, Inc, early-stage biopharmaceutical company ...
|
|
Tuesday, May 20, 2025 02:42 AM
ASBP stock touches 52-week low at $0.22 amid sharp annual decline ...
|
|
Thursday, May 08, 2025 12:06 AM
HUMACAO, PUERTO RICO AND NEW YORK, NY / ACCESS Newswire / May 8, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), a developer of a multi-faceted patent-pending ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 13/06/25 | 0.3686 | 0.3779 | 0.35 | 0.3655 | 611,763 |
| 12/06/25 | 0.40 | 0.40 | 0.369 | 0.38 | 516,378 |
| 11/06/25 | 0.3751 | 0.40 | 0.3557 | 0.3987 | 744,900 |
| 10/06/25 | 0.3903 | 0.3925 | 0.3601 | 0.38 | 1,180,152 |
| 09/06/25 | 0.39 | 0.4198 | 0.3725 | 0.395 | 1,522,987 |
| 06/06/25 | 0.3348 | 0.388 | 0.33 | 0.3805 | 2,609,646 |
| 05/06/25 | 0.39 | 0.39 | 0.3335 | 0.34 | 1,700,679 |
| 04/06/25 | 0.386 | 0.4001 | 0.3734 | 0.39 | 1,286,657 |
| 03/06/25 | 0.3617 | 0.4403 | 0.3617 | 0.384 | 3,201,004 |
| 02/06/25 | 0.4153 | 0.45 | 0.38 | 0.385 | 3,158,828 |
|
|
||||
|
|
||||
|
|